Amended Statement of Ownership (sc 13g/a)
February 11 2020 - 6:20AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
13G
Under
the Securities Exchange Act of 1934
(Amendment
No. 1)*
DelMar Pharmaceuticals, Inc.
(Name
of Issuer)
Common
Stock, $0.001 par value per share
(Title
of Class of Securities)
247078306
(CUSIP
Number)
December
31, 2019
(Date
of Event Which Requires Filing of this Statement)
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
*The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
1.
|
Names of Reporting Persons.
Mitchell P. Kopin
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ☐
(b) ☐
|
3.
|
SEC Use Only
|
4.
|
Citizenship or Place of Organization
United States of America
|
Number of
Shares Beneficially
Owned by Each
Reporting
Person With:
|
5.
|
Sole Voting Power
0
|
6.
|
Shared Voting Power
700,000
|
7.
|
Sole Dispositive Power
0
|
8.
|
Shared Dispositive Power
700,000
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
700,000 (see Item 4)
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) ☐
|
11.
|
Percent of Class Represented by Amount in Row (9)
5.8% (see Item 4)
|
12.
|
Type of Reporting Person (See Instructions)
IN; HC
|
1.
|
Names of Reporting Persons.
Daniel B. Asher
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ☐
(b) ☐
|
3.
|
SEC Use Only
|
4.
|
Citizenship or Place of Organization
United States of America
|
Number of
Shares Beneficially
Owned by Each
Reporting
Person With:
|
5.
|
Sole Voting Power
0
|
6.
|
Shared Voting Power
700,000
|
7.
|
Sole Dispositive Power
0
|
8.
|
Shared Dispositive Power
700,000
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
700,000 (see Item 4)
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) ☐
|
11.
|
Percent of Class Represented by Amount in Row (9)
5.8% (see Item 4)
|
12.
|
Type of Reporting Person (See Instructions)
IN; HC
|
1.
|
Names of Reporting Persons.
Intracoastal Capital LLC
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ☐
(b) ☐
|
3.
|
SEC Use Only
|
4.
|
Citizenship or Place of Organization
Delaware
|
Number of
Shares Beneficially
Owned by Each
Reporting
Person With:
|
5.
|
Sole Voting Power
0
|
6.
|
Shared Voting Power
700,000
|
7.
|
Sole Dispositive Power
0
|
8.
|
Shared Dispositive Power
700,000
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
700,000 (see Item 4)
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) ☐
|
11.
|
Percent of Class Represented by Amount in Row (9)
5.8% (see Item 4)
|
12.
|
Type of Reporting Person (See Instructions)
OO
|
This Amendment No.
1 is being filed jointly by the Reporting Persons and amends the Schedule 13G initially filed by the Reporting Persons with the
Securities and Exchange Commission (the “SEC”) on August 23, 2019 (the “Schedule 13G”).
Except as set forth
below, all Items of the Schedule 13G remain unchanged. All capitalized terms not otherwise defined herein shall have the meanings
ascribed to such terms in the Schedule 13G.
(b) Address of Issuer’s Principal
Executive Offices
12707 High Bluff Dr., Suite 200
San Diego, CA 92130
(a) and (b):
As of close
of business on December 31, 2019, each of the Reporting Persons may have been deemed to have beneficial ownership of 700,000 shares
of Common Stock issuable upon an exercise of a warrant held by Intracoastal (“Intracoastal Warrant 1”), and
all such shares of Common Stock represent beneficial ownership of approximately 5.8% of the Common Stock, based on (1) 11,407,513
shares of Common Stock outstanding as of November 12, 2019 as reported by the Issuer, plus (2) 700,000 shares of Common Stock issuable
upon an exercise of Intracoastal Warrant 1. The foregoing excludes 190,125 shares of Common Stock issuable upon an exercise of
a second warrant held by Intracoastal (“Intracoastal Warrant 2”) because Intracoastal Warrant 2 contains a blocker
provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 2 to the extent (but only to
the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder’s affiliates,
and any other persons acting as a group together with the holder or any of the holder’s affiliates, of more than 4.99% of
the Common Stock. Without such blocker provision, each of the Reporting Persons may have been deemed to have beneficial ownership
of 890,125 shares of Common Stock.
(c) Number of
shares as to which each Reporting Person has:
(i) Sole power to vote or to direct the vote: 0
.
(ii) Shared power to vote or to direct the vote:
700,000 .
(iii) Sole power to dispose or to direct the disposition
of 0 .
(iv) Shared power to dispose or to direct the disposition
of 700,000 .
By signing below, I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant
in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.
SIGNATURE
After reasonable inquiry
and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 11, 2020
|
/s/ Mitchell P. Kopin
|
|
Mitchell P. Kopin
|
|
|
|
|
/s/ Daniel B. Asher
|
|
Daniel B. Asher
|
|
|
|
|
Intracoastal Capital LLC
|
|
|
|
|
By:
|
/s/ Mitchell P. Kopin
|
|
|
Mitchell P. Kopin, Manager
|
Page 6 of 6
Kintara Therapeutics (PK) (USOTC:DMPWW)
Historical Stock Chart
From May 2024 to Jun 2024
Kintara Therapeutics (PK) (USOTC:DMPWW)
Historical Stock Chart
From Jun 2023 to Jun 2024